MAR 09, 2016 5:30 PM PST

Can epigenetics make better cancer drugs?

Natural killer cells that can kill and contain viruses and cancerous tumors can be manipulated by epigenetics, a finding that paves the way for developing more effective cancer drugs.
 
Understanding how a new enzyme affects natural killer cells may eventually help make cancer drugs more effective, but scientists don't yet have enough information about their molecular makeup to use them in the laboratory.

“Natural killer cells are very attractive targets for immunotherapy because they are able to kill tumor cells,” says Si-Yi Chen, professor of molecular microbiology and immunology at the Keck School of Medicine at the University of Southern California.

“While scientists all around the world are working on developing new drugs using NK cells, none of the drugs in development focuses on epigenetic regulation of the cells.”

“Our study describes how an epigenetic process involving the enzyme MYSM1 plays a critical role in the development of natural killer cells.”

Epigenetics involve biochemical changes in the body that directly affect DNA, turning some genes on and turning others off. MYSM1 is an enzyme in the body’s immune system that turns genes on and off by modifying proteins called histones embedded in DNA.

For a study published in Proceedings of the National Academy of Sciences, Chen and colleagues used mice to demonstrate that MYSM1 is required for natural killer cells to mature and function properly.

“We found that MYSM1 creates access to proteins that enhance gene transcription and, ultimately, the maturation of natural killer cells themselves,” says Ph.D. student Vijayalakshmi Nandakumar, the study’s first author.

“To date, there are no elaborate reports linking an epigenetic phenomenon to natural killer cell development. More importantly, unlike conventional therapies, NK cell-based therapies have shown to be more effective against metastasis.

“We believe cancer drugs targeting this pathway could be a viable option for future immunotherapies.”

The National Institutes of Health and a Leukemia & Lymphoma Society Specialized Center of Research Award supported the research.

Source: USC

This article was originally posted on futurity.org.
About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
NOV 17, 2020
Genetics & Genomics
Why Mutations in RRP7 Cause a Congenital Brain Disorder
NOV 17, 2020
Why Mutations in RRP7 Cause a Congenital Brain Disorder
A large family with some members that have a rare brain disorder has helped scientists learn more about both brain devel ...
DEC 21, 2020
Genetics & Genomics
Tracing the Evolution of a Deadly Microbe
DEC 21, 2020
Tracing the Evolution of a Deadly Microbe
Salmonella are human & animal bacterial pathogens that are found everywhere. When the bacterium infects a person, it cau ...
DEC 24, 2020
Microbiology
A New, Infectious Strain of SARS-CoV-2 Emerges
DEC 24, 2020
A New, Infectious Strain of SARS-CoV-2 Emerges
The UK recently reported that it had detected a new variant of the SARS-CoV-2 pandemic virus, which causes COVID-19. Thi ...
JAN 10, 2021
Genetics & Genomics
Did Sleep Precede the Brain?
JAN 10, 2021
Did Sleep Precede the Brain?
The longer we stay awake without sleeping, the more difficult it can become to think straight. But our functioning is re ...
JAN 28, 2021
Cell & Molecular Biology
Gene Variants Affecting an Ion Channel Alter Parkinson's Disease Risk
JAN 28, 2021
Gene Variants Affecting an Ion Channel Alter Parkinson's Disease Risk
These variants can raise, or lower the risk of the disease, and now researchers have learned how they work.
FEB 16, 2021
Genetics & Genomics
Genetic Tests That Look for Rare, Disease-Causing Variants are Usually Wrong
FEB 16, 2021
Genetic Tests That Look for Rare, Disease-Causing Variants are Usually Wrong
While people carry mostly the same genes, there are small differences in the sequences of those genes that can have prof ...
Loading Comments...